Drug Trial Radar · NCT05250063
Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)
Last checked: Nov 19, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Feb 18, 2022
Primary completion
Jan 22, 2025
Study completion Jan 22, 2025
Sponsor
- Lead sponsor
- Lumos PharmaIndustry
- Sponsor type
- Industry
- First posted
- Feb 22, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-national trial. The goals of the trial are to study the growth response to LUM-201 administration in children with idiopathic growth hormone deficiency (GHD) previously treated with daily rhGH for 12 months in the LUM-201-01 trial.
Conditions
- Growth Hormone Deficiency
Interventions
LUM-201Drug
Administered orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Height Velocity (AHV) Measured as Standing Height With StadiometerTime frame: Day 1 to Month 12
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
Rady Children's Hospital
San Diego, California
Children's National Hospital
Washington D.C., District of Columbia
Indiana University School of Medicine
Indianapolis, Indiana
M Health, Fairview Pediatric Specialty Clinics- Discovery Clinic
Minneapolis, Minnesota
The Children's Mercy Hospital
Kansas City, Missouri
Nationwide Children's Hospital
Columbus, Ohio
University of Virginia Health System
Charlottesville, Virginia
Klinika Endokrynologii i Chorob Metabolicznych, Instytut Centrum Zdrowia Matki Polki
Lodz, Poland
Sonomed - Centrum Medyczne
Szczecin, Poland
Klinika Endokrynologii i Diabetologii, Instytut "Pomnik Centrum Zdrowia Dziecka
Warsaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.